Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial
Safety considerations: GLP-1 receptor agonists are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
TRIUMPH-2 (obesity with type 2 diabetes, topline July 23 2026) 1,152 participants, 80 weeks
Overseas sources commonly have unverified manufacturing, inconsistent lot-to-lot specifications, and limited recourse if a vial fails specification
Research published in the Journal of Clinical Endocrinology and Metabolism found that GLP-1 receptor agonists and tirzepatide delay gastric emptying in a dose-dependent manner, with the most pronounced effects occurring after the initial dose
government picked up on the threat, the Secret Service urged Mr